PICARD MEDICAL STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Picard Medical, Inc. and Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. (NYSE: PMI) for alleged fraudulent activities that misled investors during the Class Period from September 2, 2025, to October 31, 2025 [6]. Allegation Details - The lawsuit claims that Picard failed to disclose critical information, including involvement in a fraudulent stock promotion scheme using social media misinformation and impersonation of financial professionals [6]. - It is alleged that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [6]. - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [6]. Stock Performance - On October 24, 2025, Picard's stock price experienced a significant crash of 70%, dropping to $3.99 per share [6]. - Following the crash, the share price has continued to decline, reaching approximately $2.00 per share [6]. Next Steps - Investors who purchased Picard shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire, P.C. for more information and to discuss their legal rights [4][6]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is April 3, 2026 [6].